Stocksigma LogoStocksigma Logo

Brawn Biotech Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results

Brawn Biotech Ltd has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited financial results for the quarter ended

Brawn Biotech Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results

Brawn Biotech Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

Brawn Biotech Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results Brawn Biotech Ltd has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited financial results for the quarter ended 30th Sep'26. In compliance with insider trading regulations, the company's trading window for dealing in securities remains closed until 16th Nov'26 and will reopen on 17th Nov'26.

Original exchange filing (PDF)

More announcements from Brawn Biotech Ltd

All Brawn Biotech Ltd announcements